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The objective of the current investigation was to explore whether upper body accelerations obtained during gait provide sensitive
measures of postural control in people with Parkinson’s disease (PD). Thirteen people with PD (70 ± 11 years) and nineteen
age-matched controls (70 ± 7 years) walked continuously for two minutes while wearing three inertial sensors located on their
lower back (L5), shoulder level (C7), and head. Magnitude (root mean square (RMS)), attenuation (attenuation coefficient), and
smoothness (Harmonic ratios, HR) of the accelerations were calculated. People with PD demonstrated greater RMS, particularly
in the mediolateral direction, but similar harmonic ratio of head accelerations compared to controls. In addition, they did not
attenuate accelerations through the trunk and neck as well as control participants. Our findings indicate that measuring upper
body movement provides unique information regarding postural control in PD and that poor attenuation of acceleration from the
pelvis to the head contributes to impaired head control. This information is simple to measure and appears to be sensitive to PD
and, consequently, is proposed to benefit researchers and clinicians.
1. Introduction
People with Parkinson’s disease (PD) walk with a gait pattern
that is characterised by slowness (bradykinesia), muscle
rigidity, and postural instability [1–3]. As the disease pro-
gresses, postural control deteriorates and predisposes people
with PD to falls [4–6]. Current measures of postural control,
based on the ability to maintain upright balance during quiet
stance, poorly reflect real life situations when people with PD
are at risk of falling. Consequently, researchers and clinicians
are promoting the measurement of postural control during
gait [7, 8].
The recent development of small and inexpensive wireless
inertial sensors has helped facilitate routine measurement
of postural control during gait in the clinic, laboratory, and
the community. Emerging evidence suggests that measuring
upper body acceleration during gait using inertial sensors
can objectively quantify differences in gait patterns between
those with and without PD [9, 10]. It has also been shown that
upper body accelerations are sensitive to differences between
PD fallers and nonfallers [11]. Specifically, these studies
have revealed a deterioration of the smoothness of trunk
accelerations in people with PD as measured by harmonic
ratios, which was more pronounced in those with a history
of falls.
Despite emerging evidence that maintaining head stabil-
ity during gait is a key determinant of postural control [12–
16], accelerations of the head have been neglected in these
previous studies examining upper body acceleration in PD.
One potential reason head stability is important is that the
head contains the visual and vestibular systems, which are
critical for navigation and preplanning of adaptive motor
strategies [13]. Head stability may have added importance
for people with PD because they rely heavily on vision to
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maintain their postural control [5]. Recent evidence suggests
that vision during gait is affected in PD [17] and that the
smoothness of trunk accelerations is also altered [9, 10].
However, it has not yet been established whether PD affects
the stability of the head during gait. A key mechanism in
maintaining head stability is the attenuation of accelerations
through the trunk. People with PD often develop axial
rigidity, which may impair their ability to attenuate the
accelerations that are applied to the lower limbs during
gait from impacting on head stability. The measurement of
attenuation of accelerations through the upper body has
previously been investigated as a strong postural control
indicator for children, adults, and elderly individuals [18–21]
but has not yet been examined in people with PD.
The objective of the current investigation was to explore
whether upper body accelerations obtained during gait pro-
vide sensitive proxy measures of postural control in people
with Parkinson’s disease (PD). More specifically, the aims of
this study were to assess the magnitude, attenuation, and
smoothness of upper body accelerations in people with PD
compared to age-matched controls. We tested the hypotheses
that: people with PD would demonstrate impaired smooth-
ness and attenuation of accelerations. To address these aims,
accelerations of the head, trunk, and pelvis were assessed
during gait in a cohort of people with PD and an age-matched
control group.
2. Materials and Methods
2.1. Participants. A subsection of community dwelling older
adults and people with PD were tested as part of the
ongoing ICICLE-PD (Incidence of Cognitive Impairment in
Cohorts with Longitudinal Evaluation—Parkinson’s Disease)
Gait study [22, 23]. Participants were excluded if they had any
neurological (other than PD), orthopaedic, or cardiothoracic
conditions that may have markedly affected their walking or
safety during the testing sessions. In addition, PDparticipants
had to be diagnosed with idiopathic PD according to the UK
Parkinson’s Disease Brain Bank criteria and were excluded if
they presented with significant memory impairment (Mini
Mental State Exam (MMSE) ≤ 24 [24]), dementia with Lewy
bodies, drug induced parkinsonism, “vascular” parkinson-
ism, progressive supranuclear palsy, multiple system atrophy,
corticobasal degeneration, or poor command of English.This
studywas conducted according to theDeclaration ofHelsinki
and had ethical approval from the Newcastle and North
Tyneside research ethics committee. All participants signed
an informed consent form.
2.2. Experimental Protocol. All participants walked for two
minutes at their preferred pace around a 25m circuit, fully
described in [27]. Spatiotemporal gait variables (walking
speed, step time, step length, and step width) were mea-
sured using a 7m long Gaitrite pressure activated electronic
walkway (Platinummodel Gaitrite, software version 4.5, CIR
systems, United States of America). Upper body accelerations
weremeasured using three OPAL inertial sensors sampling at
128Hz (APDMInc, Portland,OR,USA) located at 5th lumbar
vertebra to represent the pelvis level (P), the 7th cervical
vertebra to represent the shoulder level (S) and upon the back
of the head (H). The Gaitrite and the OPAL system were
synchronised and the data was collected using the same A/D
converter.
2.3. Data Analysis. To ensure only steady-state, straight-line
walking was analysed, only the portion of the acceleration
data recorded while participants who were in contact with
the Gaitrite walkway was used. As detailed in Mazza` et
al. [20], prior to collecting the gait data, a calibration trial
was captured using a sensor placed on the floor to create a
global reference frame for the laboratory.Thereafter, the local
reference frame of each sensor was reoriented for each time
sample to the newly established global reference frame [19,
28]. Following, the acceleration data was further segmented
based upon the foot contact and foot off values obtained
from the Gaitrite walkway.Then, the mean value of the signal
was removed and a low-pass fourth order Butterworth filter
with a cut-off frequency of 10Hz was applied [19]. Data for
each stride was normalised to 100 data points using linear
interpolation. All signals were processed using MATLAB
(version 8.1.0).
2.4. Magnitude of Acceleration. The magnitude of accelera-
tions was calculated using the root mean square (RMS) of the
accelerations, measured by each sensor for each stride in the
Anteroposterior (AP), Mediolateral (ML), and Vertical (V)
directions.
2.5.Attenuation ofAcceleration. Theability to attenuate accel-
erations through the upper body was quantified using the
attenuation coefficient. The attenuation coefficient describes
the ability to reduce accelerations from inferior to the supe-
rior anatomical locations and was calculated using the RMS
values for each stride.
The attenuation coefficients were computed using the
RMS values of the head (RMSH), shoulder (RMSS), and pelvis
(RMSP) as follows [18–20]:
𝐶PH = (1 −
RMSH
RMSP
) × 100,
𝐶PS = (1 −
RMSS
RMSP
) × 100,
𝐶SH = (1 −
RMSH
RMSS
) × 100
(1)
with 𝐶PH representing the attenuation from the pelvis to the
head, 𝐶PS representing the attenuation from the pelvis to
the shoulder, and 𝐶SH representing the attenuation from the
shoulder to the head. Each equation provides a percentage
representing the amount of acceleration that is attenuated
from the inferior sensors to the superiorly located sensor. A
positive coefficient indicates reduced acceleration at the supe-
riorly located sensor relative to the inferiorly located sensor.
A negative coefficient value indicates a greater acceleration at
the superiorly located sensor.
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Table 1: The mean (±SD) participant characteristics and spatial-temporal gait variables for the PD and control group.
PD (𝑛 = 13) Control (𝑛 = 19) 𝑃 (𝑡-test)
Age (years) 69.7 ± 11.1 70.2 ± 6.7 0.90
Height (m) 1.70 ± 0.10 1.72 ± 0.10 0.99
Mass (Kg) 77.9 ± 13.3 83.2 ± 14.2 0.30
BMI 26.1 ± 3.3 28.0 ± 4.5 0.20
MDS UPDRS III 35.6 ± 12.6 NA NA
Hoehn and Yahr stage HY II: 11; HY III: 2 NA NA
Gait speed (m/s2) 1.22 ± 0.22 1.32 ± 0.15 0.14
Step time (s) 0.54 ± 0.21 0.54 ± 0.44 0.97
Step length (cm) 0.66 ± 0.12 0.71 ± 0.07 0.15
Step width (cm) 0.09 ± 0.03 0.09 ± 0.02 0.46
∗Significant difference at 𝑃 < 0.05.
BMI: body mass index.
MDS UPDRS III: Movement Disorders Society Revised Unified Parkinson’s Disease Rating Scale–Movement Subsection [25].
HY: Hoehn and Yahr stage [26].
2.6. Smoothness of Accelerations. We quantified the smooth-
ness of upper body accelerations using the harmonic ratio
(HR).TheHRaccurately describes the step-to-step symmetry
within a stride but for upper body gait analysis is also
commonly referred to as a measure smoothness [29]. The
HR was calculated via discrete Fourier transform for each
of the acceleration components measured at the H, S, and P
levels in the AP, ML, and V directions [30]. The fundamental
frequency was set equal to the stride frequency.
For the AP and V Components, the HRWas Defined as:
HR = Σ Amplitudes of even harmonics
Σ Amplitudes of odd harmonics (2)
For the ML Component, the HRWas Defined as:
HR = Σ Amplitudes of odd harmonics
Σ Amplitudes of even harmonics (3)
Higher values of HR are associated with a higher similarity
between the pattern of the upper body movements occurring
during the right and left steps and are therefore favourable [9,
31]. Following calculation, the HR’s were normalised to each
participant’s gait speed [9, 14].
2.7. Statistical Analysis. A series of two-tailed paired 𝑡-tests
were used to test the difference between groups for the
magnitude, attenuation, and smoothness of accelerations.
The level of significance was set at 𝑃 = 0.05. Given the
exploratory nature of this study, the 𝑃 value was not adjusted
for multiple comparisons.
3. Results
The characteristics of the participants are reported in Table 1.
All the participants with PDwere tested within 18–54months
post diagnosis. No significant differenceswere found between
the two groups in terms of anthropometric characteristics or
spatiotemporal gait values.
3.1. Magnitude of Acceleration. Significantly higher ML head
accelerations were observed in people with PD compared to
controls (1.08 ± 0.29m/s2 versus 0.86 ± 0.21m/s2, 𝑃 = 0.024)
but not at the pelvis or the shoulder level. There were no
other significant between-group differences although AP and
V head accelerations tended to be greater in the PD group
(Table 2).
3.2. Attenuation of Acceleration. People with PD did not
attenuate AP or ML accelerations as well as controls
(Figure 1). For 𝐶PH, a significant difference existed between
PD and the control participants in the ML direction (0.12 ±
34.7% versus 33.8 ± 21.3%, 𝑃 = 0.003). For 𝐶PS, a significant
difference existed between PD and controls in the AP (16.0 ±
15.6% versus 33.1 ± 12.4%, 𝑃 = 0.002), as well as the ML
direction (5.5 ± 24.5% versus 27.7 ± 18.6%, 𝑃 = 0.009).
For 𝐶SH, a significant difference existed between the PD and
the control group in the ML direction (−3.6 ± 15.5% versus
9.4 ± 15.3%, 𝑃 = 0.031).
3.3. Harmonic Ratio. The HRs normalised to gait speed
showed no significant differences between the PD and control
participants (Table 3).
4. Discussion
Our current investigation provides evidence that upper body
accelerations obtained during gait provide sensitivemeasures
of postural control in people with Parkinson’s disease (PD).
As hypothesised, the results of this study showed that people
with PD walked with altered upper body accelerations com-
pared to age-matched controls. In particular, people with PD
walked with greater magnitude of ML head accelerations and
demonstrated impaired attenuation of accelerations from the
pelvis and neck to the head. In contrast to our hypothesis,
smoothness of upper body accelerations as measured by the
HR was not significantly affected in this sample of PD.
To our knowledge, this is the first study to show impaired
head stability in people with PD using inertial sensors. A
greater magnitude of ML head acceleration was found for
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Table 2: The mean (±SD) root mean square (RMS) for the PD and
the control participants calculated at the head (H), shoulder (S), and
the pelvis (P) levels.
Sensor
location Component PD Control 𝑃 (t-test)
H
AP 1.02 ± 0.24 0.92 ± 0.20 0.22
ML 1.08 ± 0.29 0.86 ± 0.21 0.02∗
V 2.15 ± 0.74 2.41 ± 0.47 0.26
S
AP 1.03 ± 0.18 0.96 ± 0.16 0.31
ML 1.05 ± 0.24 0.96 ± 0.17 0.25
V 2.04 ± 0.64 2.28 ± 0.46 0.24
P
AP 1.28 ± 0.38 1.47 ± 0.33 0.14
ML 1.17 ± 0.36 1.41 ± 0.42 0.11
V 2.16 ± 0.70 2.35 ± 0.47 0.37
∗Significant difference at 𝑃 < 0.05.
H: head; S: shoulder level; P: pelvis.
AP: anterior/posterior; ML: medial/lateral; V: vertical.
Table 3:Themean (±SD) Harmonic ratios normalised to gait speed
for the PD and the control participants calculated at the head (H),
shoulder (S), and the pelvis (P) levels.
Sensor
location Component PD Control 𝑃 (𝑡-test)
H
AP 0.71 ± 0.36 0.53 ± 0.23 0.11
ML 1.22 ± 0.56 1.02 ± 0.38 0.27
V 2.03 ± 0.57 2.18 ± 0.60 0.50
S
AP 0.70 ± 0.23 0.66 ± 0.22 0.64
ML 0.80 ± 0.50 0.80 ± 0.22 0.95
V 2.34 ± 0.77 2.51 ± 0.72 0.55
P
AP 1.22 ± 0.38 1.13 ± 0.48 0.61
ML 1.05 ± 0.69 0.80 ± 0.38 0.22
V 2.02 ± 0.60 2.17 ± 2.17 0.58
H: head; S: shoulder level; P: pelvis.
AP: anterior/posterior; ML: medial/lateral; V: vertical.
the PD group.Thiswas interpreted as a result of poor postural
control for the PD participants and a failure to stabilise their
head in space [18, 21]. High values for the head accelerations
have been previously described as a reduced ability to stabilise
the head in space. This is particularly crucial for people with
PD because of their aforementioned increased dependence
upon visual input for correcting postural control [5]: higher
accelerations are likely disturbing their visual system, leading
to an impaired ability to preplan effective motor strategies
[13], causing an increased likelihood to fall. Although they
might be a useful measure of postural control, RMS values
of head accelerations are known to be dependent upon step
length and gait speed [31]. Despite no significant differences
being observed for these parameters between the PD and
the control group in this sample, it is common that PD
affects both gait speed and step length [1–3]. As a result, the
magnitude of accelerationsmay lack sensitivity when used for
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Figure 1: Mean (±SD) values of the attenuation coefficients (𝐶PH,
𝐶PS, and 𝐶SH) of the three acceleration components (AP = ante-
rior/posterior, ML = medial/lateral; V = vertical), computed for the
control and group with PD. ∗𝑃 < 0.05.
discriminating PD patients, which in other studies have been
shown to possess a decreased step length and gait speed, when
compared to age-matched controls.
Alternatively, being computed as a ratio between acceler-
ations measured during the same trial [18], the coefficients of
attenuation do not suffer from being speed dependent. In the
current investigation; the coefficients of attenuation provided
insight into why the PD participants demonstrated greater
accelerations at the head. Participants with PD were less
able to attenuate accelerations through the trunk, as shown
by impaired pelvis-shoulder attenuation coefficients, which
were reduced on average by at least a half in the PD cohort,
both in the AP and in the ML direction. It is not possible
to fully explain why the people with PD did not attenuate
accelerations well through the upper body; however, it may
be associated with en bloc movement and axial rigidity. It
has previously been stated that increased rigidity may cause
underlying changes in the physiological and mechanical
functioning of the axial muscles which results in en bloc
movement, where the head, trunk and pelvis move together
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as one rigid unit [12, 32]. It might be assumed that the
same mechanisms could be responsible for poor attenuation
of accelerations through the spine in PD. However, more
research is certainly needed to test this hypothesis and explain
the mechanisms ruling altered head accelerations and poor
attenuation in PD, as well as the implications of poor head
stability on vision and postural control.
Interestingly, the findings regarding attenuation coeffi-
cients were strongest in the ML direction. Similar results
were found even when analysing healthy elderly subjects
[21]. The fact that instability was predominantly found in the
ML direction, suggests that when utilising a coefficient of
attenuation, the ML direction is potentially most informative
of an impaired walking stability. Consequently, assessments
in the ML direction may be best for proxy measures of
postural control in PD.
In contrast with our hypothesis and previous studies
[9], the smoothness of upper body accelerations (harmonic
ratios) was not significantly affected in our sample of PD par-
ticipants. The discrepancy with previous studies is unlikely
due tomethodological differences, as the studies were similar
in design. It is possible, however, that we were statistically
underpowered to detect group difference, as suggested by a
25% reduction of AP HRs and 16% reduction of ML HRs
at the head in the PD group that did not reach statistical
significance (𝑃 = 0.106). Further research is required to
determine the effectiveness of harmonic ratios as a sensitive
measure to PD at different stages of their disease progression,
as well as its ability to predict future falls.
Clinicians require objective measures to assess postural
control during locomotion in people with PD to supplement
standard clinical assessments and conventional rating scales
which are not sensitive to subtle postural control disturbance
[31, 33, 34]. Our findings indicate that it is feasible to measure
the magnitude, attenuation, and smoothness of upper body
accelerations in people with PD using body worn sensors.
The rapid technological development of inertial sensors
may afford a quick, clinically appropriate, and cost effective
method to measure postural control in the clinic and com-
munity settings [5]. Specifically, the attenuation coefficient
is a promising measure that is sensitive to PD; however,
larger longitudinal studies are needed to assess its ability to
monitor disease progression, determine intervention efficacy,
and inform clinical management [5, 34, 35].
5. Conclusion
The current investigation suggests that assessing upper body
acceleration offers additional and unique information about
postural control during gait in people with PD. In particular,
the magnitude of ML head accelerations and attenuation
of upper body acceleration appear sensitive to PD and
consequently hold promise as useful proxymeasures that can
be utilised in clinical and community settings.
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